Loading clinical trials...
Loading clinical trials...
This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase III study to evaluate the efficacy and safety of KPS-0373 given once daily after breakfast in 142 patients wi...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Kissei Pharmaceutical Co., Ltd Kissei Pharmaceutical Co., Ltd
CONTACT
Email onlyrinsyousiken@pharm.kissei.co.jpLead Sponsor
Kissei Pharmaceutical Co., Ltd.
NCT01970098 · Spinocerebellar Degeneration
NCT01970111 · Spinocerebellar Degeneration
NCT01970124 · Spinocerebellar Degeneration
NCT00863538 · Spinocerebellar Degeneration
Research Site
Multiple Locations
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions